DOCSLIB.ORG

P31comet and TRIP13 Recycle Rev7 to Regulate DNA Repair COMMENTARY Kevin D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
P31comet and TRIP13 Recycle Rev7 to Regulate DNA Repair COMMENTARY Kevin D COMMENTARY p31comet and TRIP13 recycle Rev7 to regulate DNA repair COMMENTARY Kevin D. Corbetta,b,c,1 Proteins of the HORMA domain family, named for its of Rev7’s roles in two important DNA repair pathways: three founding members Hop1, Rev7, and Mad2, play translesion DNA synthesis and DNA double-strand key roles in a broad range of eukaryotic signaling break (DSB) repair. Rev7 was first characterized as a pathways, from chromosome segregation and meiotic subunit of DNA polymerase ζ, which aids replication recombination, to DNA repair, to the initiation of of DNA past lesions that stall replicative polymerases autophagy (1). The HORMA domain nucleates assem- (23, 24). A groundbreaking recent structure of the po- bly of multiprotein signaling complexes by wrapping lymerase ζ holoenzyme shows that a dimer of Rev7 its C-terminal “safety belt” region entirely around a coordinates assembly of this complex by binding short, 6- to 10-amino acid “closure motif” in a binding two closure motifs (also called Rev7-binding motifs partner, resulting in a highly stable complex (Fig. 1A). or RBMs) in the catalytic Rev3 subunit, and mediating While the mechanisms governing assembly of interactions with the accessory subunits Pol31 and HORMA protein signaling complexes vary, many Pol32 (25). At the same time, Rev7 binds a second HORMA proteins share a common disassembly path- DNA polymerase, Rev1, which, in turn, recruits addi- way involving two proteins, p31comet and the AAA+ tional Y-family DNA polymerases like Polη,Polι,and ATPase TRIP13. p31comet, itself a diverged HORMA Polκ (26). In this manner, Rev7 functionally links the ac- protein, specifically binds HORMA proteins in their tivity of Y-family “inserter” polymerases that insert a “closed” partner-bound conformation, and recruits base directly opposite a DNA lesion with that of the them to TRIP13 (2–4). TRIP13 partially unfolds the “extender” polymerase Rev3 that synthesizes past the HORMA domain, releasing the bound closure motif lesion for eventual handoff to a replicative polymerase. and converting the substrate HORMA protein to an In vertebrates, Rev7 plays a second key role in inactive “open” conformation poised for rebinding DNA repair through the newly discovered Shieldin (5–10). This HORMA recycling pathway was first de- complex, which regulates DSB repair pathway choice scribed for the spindle assembly checkpoint protein (27). Cells possess two major pathways for DSB repair: Mad2 (11–13), and has since been extended to in- the homologous recombination (HR) pathway that clude the meiotic recombination factor Hop1 and its uses an unbroken DNA template to mediate error- relatives, collectively termed meiotic HORMADs free repair, and the more error-prone nonhomologous (14–20). A key question has been whether TRIP13 end-joining (NHEJ) pathway. HR and NHEJ are tightly and p31comet regulate other HORMA protein families, regulated during the cell cycle, with NHEJ dominant including the DNA repair factor Rev7 and the auto- in G1, and HR dominant in S and G2 when a sister phagy regulators Atg13 and Atg101. In two recent chromosome generated by DNA replication is avail- manuscripts, Clairmont et al. (21) and Sarangi et al. able as a repair template. A key factor in repair path- (22) provide convincing evidence that TRIP13 and way choice is the Shieldin complex, which comprises p31comet regulate Rev7 function in two DNA repair Rev7, SHLD1, SHLD2, and SHLD3. A recent structure pathways, and that overexpression of TRIP13 and/or of the Rev7−SHLD2−SHLD3 subcomplex revealed p31comet in cancer causes resistance to a widely used that a dimer of Rev7 nucleates Shieldin assembly class of anticancer drugs known as Poly-ADP ribose through a complex set of interactions, including bind- polymerase (PARP) inhibitors. ing to a closure motif in SHLD3 (28). In the cell, Shiel- Rev7 has long been under-studied compared to din is recruited to DSB sites by 53BP1 and Rif1, where Mad2 and the meiotic HORMADs, but recent years it inhibits DNA end resection to suppress HR and pro- have witnessed a renaissance in our understanding mote NHEJ (Fig. 1B) (27). aDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093; bDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093; and cSan Diego Branch, Ludwig Institute for Cancer Research, La Jolla, CA 92093 Author contributions: K.D.C. wrote the paper. The author declares no competing interest. Published under the PNAS license. See companion article, “p31comet promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase,” 10.1073/pnas. 2008830117. 1Email: [email protected]. www.pnas.org/cgi/doi/10.1073/pnas.2020103117 PNAS Latest Articles | 1of3 Downloaded at UNIV OF CALIF SAN DIEGO on October 29, 2020 Fig. 1. Regulation of HORMA proteins by p31comet and TRIP13. (A) HORMA-mediated signaling is activated when an open HORMA domain (light blue) binds a closure motif (yellow) in a binding partner and converts to the closed conformation (dark blue). To inactivate signaling, p31comet binds a HORMA-closure motif complex and recruits it to TRIP13 for disassembly. (B) Healthy cells maintain a balance between two DNA DSB repair pathways, HR and NHEJ. When recruited to DNA ends by 53BP1/Rif1, Rev7-Shieldin inhibits DNA end resection to suppress HR. In − − HR-deficient BRCA1 / cancers, PARP inhibition leads to increased DNA breaks and cell death. Overexpression of TRIP13 and/or p31comet in these cells reactivates HR to promote PARP inhibitor resistance, cell survival, and proliferation. −/− Given its central roles in two major DNA repair pathways, one Clairmont et al. (21) and Sarangi et al. (22) find that BRCA1 cells important question is whether Rev7, like the related Mad2 and overexpressing TRIP13 or p31comet become resistant to the PARP meiotic HORMADs, is regulated by the TRIP13/p31comet HORMA inhibitor Olaparib, and show that this resistance arises through reac- recycling pathway. In two recent studies, Clairmont et al. (21) and tivation of HR-mediated DNA repair due to lowered Shieldin com- Sarangi et al. (22) provide convincing evidence that TRIP13 and plex levels (Fig. 1B). Thus, inhibition of TRIP13/p31comet-mediated p31comet regulate Rev7 through conformational recycling and Shieldin disassembly may represent a promising treatment strat- Rev7-closure motif complex disassembly. The two studies show egy for patients with BRCA1-deficient cancers that develop resis- comet that TRIP13 and p31 physically interact with Rev7 and medi- tance to PARP inhibitors. ate disassembly of Shieldin and polymerase ζ, both in vitro and in Many questions remain with respect to the roles of TRIP13 comet cells. Overexpression of TRIP13 or p31 reduces association of and p31comet in healthy cells and in disease. First, while Clairmont Rev7 with SHLD3 and, in turn, increases DNA end resection at et al. (21) show that Rev7 can adopt two folded states in solution, comet DSBs and promotes their repair by HR. TRIP13/p31 overex- how these two states correspond to Mad2’s well-defined open pression also reduces the association of Rev7 with Rev3 and im- and closed conformations requires additional exploration. An- ’ pairs cells ability to repair DNA lesions caused by ultraviolet other question is whether and how Rev7 recycling is regulated radiation and the interstrand crosslinker mitomycin C, demon- through the cell cycle. Two studies have reported that p31comet strating a defect in translesion DNA synthesis. These data firmly is phosphorylated during mitosis to suppress disassembly of mi- comet ’ establish a role for TRIP13 and p31 in regulating Rev7 s func- totic checkpoint complexes (30, 31); whether this or other regula- tion in two important DNA repair pathways. comet tory mechanisms applies to Rev7 regulation is unknown. Finally, A direct role for TRIP13 and p31 in Rev7 regulation can comet whether TRIP13 and p31 regulate autophagy through Atg13 also explain these proteins’ contributions to cancer. TRIP13 is and Atg101, or other signaling pathways through as yet undiscov- known to be overexpressed in many human cancers, and Sarangi ered HORMA proteins, remains mostly unexplored. While many et al. (22) now find that p31comet overexpression is also common in questions remain, the studies by Clairmont et al. (21) and Sarangi cancer. Moreover, high TRIP13 and/or p31comet levels correlate et al. (22) provide significant insight into HORMA recycling by with poor prognosis across many cancer types (21, 22). While in- TRIP13 and p31comet, and clearly define a key connection between creased HORMA recycling activity in cancerous cells likely impacts these proteins and human disease. many HORMA-dependent signaling pathways, Clairmont et al. (21) and Sarangi et al. (22) demonstrate that Shieldin-regulated DSB repair is of particular clinical relevance. Many cancers lose the Acknowledgments ability to repair DNA breaks by HR through mutation or loss of I thank members of the Corbett laboratory and A. Desai for critical reading and BRCA1, and these cancers are sensitive to inhibition of PARP (29). helpful suggestions, and the NIH (Grant R01 GM104141) for support. 1 S. C. Rosenberg, K. D. Corbett, The multifaceted roles of the HORMA domain in cellular signaling. J. Cell Biol. 211, 745–755 (2015). 2 M. Yang et al., p31comet blocks Mad2 activation through structural mimicry. Cell 131,744–755 (2007). 3 T. Habu, S. H. Kim, J. Weinstein, T. Matsumoto, Identification of a MAD2-binding protein, CMT2, and its role in mitosis. EMBO J. 21, 6419–6428 (2002). 4 G. Xia et al., Conformation-specific binding of p31(comet) antagonizes the function of Mad2 in the spindle checkpoint. EMBO J. 23,3133–3143 (2004). 5 A. R. Tipton et al., Identification of novel mitosis regulators through data mining with human centromere/kinetochore proteins as group queries. BMC Cell Biol. 13, 15 (2012). 6 K. Wang et al., Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint-silencing protein.
Load more

Recommended publications
  • Biallelic TRIP13 Mutations Predispose to Wilms Tumor and Chromosome Missegregation
    Europe PMC Funders Group Author Manuscript Nat Genet. Author manuscript; available in PMC 2017 July 01. Published in final edited form as: Nat Genet. 2017 July ; 49(7): 1148–1151. doi:10.1038/ng.3883. Europe PMC Funders Author Manuscripts Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation Shawn Yost#1, Bas de Wolf#2, Sandra Hanks#1, Anna Zachariou1, Chiara Marcozzi3,4, Matthew Clarke1, Richarda de Voer2, Banafsheh Etemad2, Esther Uijttewaal2, Emma Ramsay1, Harriet Wylie1, Anna Elliott1, Susan Picton5, Audrey Smith6, Sarah Smithson7, Sheila Seal1, Elise Ruark1, Gunnar Houge8, Jonathan Pines3,4, Geert J.P.L. Kops2,9,10,+, and Nazneen Rahman1,11,+ 1Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK 2Hubrecht Institute – KNAW (Royal Netherlands Academy of Arts and Sciences), Uppsalalaan 8, 3584 CT Utrecht, The Netherlands 3The Gurdon Institute and Department of Zoology, University of Cambridge, Cambridge CB2 1QN, UK 4Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK 5Children's and Adolescent Oncology and Haematology Unit, Leeds General Infirmary, Leeds, LS1 3EX, UK 6Yorkshire Regional Clinical Genetics Service, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK 7Clinical Genetics Service, St Michael's Hospital, Southwell Street, Bristol, BS2 8EG, UK 8Center for Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway 9Cancer Genomics Netherlands, Utrecht, The Netherlands 10Center for Molecular 11 Europe PMC Funders Author Manuscripts Medicine, University Medical Center Utrecht, 3584 CG, Utrecht, The Netherlands Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK SM2 5PT, UK # These authors contributed equally to this work.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, SAN DIEGO Identifying the Contributions and Mechanisms of P31comet and TRIP13 Function During Mitotic
    UNIVERSITY OF CALIFORNIA, SAN DIEGO Identifying the Contributions and Mechanisms of p31comet and TRIP13 Function During Mitotic Checkpoint Silencing A thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Biology by Kimia Candice Mashouf Committee in charge: Professor Don Cleveland, Chair Professor Gen-sheng Feng, Co-chair Professor Samara Reck-Peterson 2016 Copyright Kimia Candice Mashouf, 2016 All rights reserved The Thesis of Kimia Candice Mashouf is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Co-Chair _____________________________________________________________________ Chair University of California, San Diego 2016 iii TABLE OF CONTENTS Signature Page……………………………………………………………………………….. iii Table of Contents…………………………………………………………………………….. iv List of Figures…………………………………………………………………………………. v Acknowledgments…………………………………………………………………..………... vi Abstract of Thesis…….…………………………………………………………………….... vii Chapter 1: Introduction………………………………………………………………….…… 1 Chapter 2: Materials and Methods…………………………………………………….…… 6 Chapter 3: Results…………………………………………………………………………... 10 Chapter 4: Discussion………………………………………………………………………. 16 Appendix……………………………………………………………………………………… 19 References…………………………………………………………………………………… 20 iv LIST OF FIGURES Figure 1: Kinetochore Activation of the checkpoint through hierarchical checkpoint protein recruitment………………………………………….…………………... 2 Figure 2: Disassembly Approach to Identify the functions of TRIP13 and p31 comet on the the
    [Show full text]
  • Identification of Conserved Genes Triggering Puberty in European Sea
    Blázquez et al. BMC Genomics (2017) 18:441 DOI 10.1186/s12864-017-3823-2 RESEARCHARTICLE Open Access Identification of conserved genes triggering puberty in European sea bass males (Dicentrarchus labrax) by microarray expression profiling Mercedes Blázquez1,2* , Paula Medina1,2,3, Berta Crespo1,4, Ana Gómez1 and Silvia Zanuy1* Abstract Background: Spermatogenesisisacomplexprocesscharacterized by the activation and/or repression of a number of genes in a spatio-temporal manner. Pubertal development in males starts with the onset of the first spermatogenesis and implies the division of primary spermatogonia and their subsequent entry into meiosis. This study is aimed at the characterization of genes involved in the onset of puberty in European sea bass, and constitutes the first transcriptomic approach focused on meiosis in this species. Results: European sea bass testes collected at the onset of puberty (first successful reproduction) were grouped in stage I (resting stage), and stage II (proliferative stage). Transition from stage I to stage II was marked by an increase of 11ketotestosterone (11KT), the main fish androgen, whereas the transcriptomic study resulted in 315 genes differentially expressed between the two stages. The onset of puberty induced 1) an up-regulation of genes involved in cell proliferation, cell cycle and meiosis progression, 2) changes in genes related with reproduction and growth, and 3) a down-regulation of genes included in the retinoic acid (RA) signalling pathway. The analysis of GO-terms and biological pathways showed that cell cycle, cell division, cellular metabolic processes, and reproduction were affected, consistent with the early events that occur during the onset of puberty.
    [Show full text]
  • The Mechanisms of the Spindle Assembly Checkpoint and Mitotic Cell Death
    The Mechanisms of the Spindle Assembly Checkpoint and Mitotic Cell Death Jianquan Li Thesis submitted to Newcastle University in candidature for the degree of Doctor of Philosophy Institute for Cell and Molecular Bioscience Newcastle University October 2018 Abstract The spindle assembly checkpoint (SAC) monitors the chromosomes and kinetochore– microtubule attachment to prevent premature anaphase onset (Lara-Gonzalez et al., 2012), and this ensures the fidelity of cell division. The mitotic checkpoint complex (MCC), the core SAC effector, contains two sub-complexes, CDC20-MAD2 and BUBR1-BUB3 (Sudakin et al., 2001). However, the exact mechanism underlying the assembly of the MCC regarding when, where and how still is not fully addressed. It is believed that the formation of the CDC20-MAD2 sub-complex is an initial and essential step in MCC assembly (Sudakin et al., 2001), thus the assembly of the MCC can be depicted by the observation of the formation of the CDC20-MAD2 complex (Fraschini et al., 2001, Meraldi et al., 2004, Poddar et al., 2005). Using the Duolink based in situ proximity ligation assay (PLA), the lab has previously used individual cell analysis to show the temporal and spatial in vivo formation of the CDC20-MAD2 complex throughout the cell cycle in HeLa cells and existence of a specific prophase form of the CDC20-MAD2 complex (Li et al., 2017). In this study, we provide evidences showing that the profile of the assembly of the CDC20-MAD2 complex revealed by using the PLA can genuinely reflect the dynamic in vivo interaction of these two proteins in individual cells.
    [Show full text]
  • Genome-Wide DNA Methylation Dynamics During Epigenetic
    Gómez‑Redondo et al. Clin Epigenet (2021) 13:27 https://doi.org/10.1186/s13148‑021‑01003‑x RESEARCH Open Access Genome‑wide DNA methylation dynamics during epigenetic reprogramming in the porcine germline Isabel Gómez‑Redondo1*† , Benjamín Planells1†, Sebastián Cánovas2,3, Elena Ivanova4, Gavin Kelsey4,5 and Alfonso Gutiérrez‑Adán1 Abstract Background: Prior work in mice has shown that some retrotransposed elements remain substantially methylated during DNA methylation reprogramming of germ cells. In the pig, however, information about this process is scarce. The present study was designed to examine the methylation profles of porcine germ cells during the time course of epigenetic reprogramming. Results: Sows were artifcially inseminated, and their fetuses were collected 28, 32, 36, 39, and 42 days later. At each time point, genital ridges were dissected from the mesonephros and germ cells were isolated through magnetic‑ activated cell sorting using an anti‑SSEA‑1 antibody, and recovered germ cells were subjected to whole‑genome bisulphite sequencing. Methylation levels were quantifed using SeqMonk software by performing an unbiased analysis, and persistently methylated regions (PMRs) in each sex were determined to extract those regions showing 50% or more methylation. Most genomic elements underwent a dramatic loss of methylation from day 28 to day 36, when the lowest levels were shown. By day 42, there was evidence for the initiation of genomic re‑methylation. We identifed a total of 1456 and 1122 PMRs in male and female germ cells, respectively, and large numbers of transpos‑ able elements (SINEs, LINEs, and LTRs) were found to be located within these PMRs. Twenty‑one percent of the introns located in these PMRs were found to be the frst introns of a gene, suggesting their regulatory role in the expression of these genes.
    [Show full text]
  • Disruption of the Anaphase-Promoting Complex Confers Resistance to TTK Inhibitors in Triple-Negative Breast Cancer
    Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer K. L. Thua,b, J. Silvestera,b, M. J. Elliotta,b, W. Ba-alawib,c, M. H. Duncana,b, A. C. Eliaa,b, A. S. Merb, P. Smirnovb,c, Z. Safikhanib, B. Haibe-Kainsb,c,d,e, T. W. Maka,b,c,1, and D. W. Cescona,b,f,1 aCampbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7; bPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7; cDepartment of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 1L7; dDepartment of Computer Science, University of Toronto, Toronto, ON, Canada M5G 1L7; eOntario Institute for Cancer Research, Toronto, ON, Canada M5G 0A3; and fDepartment of Medicine, University of Toronto, Toronto, ON, Canada M5G 1L7 Contributed by T. W. Mak, December 27, 2017 (sent for review November 9, 2017; reviewed by Mark E. Burkard and Sabine Elowe) TTK protein kinase (TTK), also known as Monopolar spindle 1 (MPS1), ator of the spindle assembly checkpoint (SAC), which delays is a key regulator of the spindle assembly checkpoint (SAC), which anaphase until all chromosomes are properly attached to the functions to maintain genomic integrity. TTK has emerged as a mitotic spindle, TTK has an integral role in maintaining genomic promising therapeutic target in human cancers, including triple- integrity (6). Because most cancer cells are aneuploid, they are negative breast cancer (TNBC). Several TTK inhibitors (TTKis) are heavily reliant on the SAC to adequately segregate their abnormal being evaluated in clinical trials, and an understanding of karyotypes during mitosis.
    [Show full text]
  • The Genetic Program of Pancreatic Beta-Cell Replication in Vivo
    Page 1 of 65 Diabetes The genetic program of pancreatic beta-cell replication in vivo Agnes Klochendler1, Inbal Caspi2, Noa Corem1, Maya Moran3, Oriel Friedlich1, Sharona Elgavish4, Yuval Nevo4, Aharon Helman1, Benjamin Glaser5, Amir Eden3, Shalev Itzkovitz2, Yuval Dor1,* 1Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. 3Department of Cell and Developmental Biology, The Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel 4Info-CORE, Bioinformatics Unit of the I-CORE Computation Center, The Hebrew University and Hadassah, The Institute for Medical Research Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 5Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel *Correspondence: [email protected] Running title: The genetic program of pancreatic β-cell replication 1 Diabetes Publish Ahead of Print, published online March 18, 2016 Diabetes Page 2 of 65 Abstract The molecular program underlying infrequent replication of pancreatic beta- cells remains largely inaccessible. Using transgenic mice expressing GFP in cycling cells we sorted live, replicating beta-cells and determined their transcriptome. Replicating beta-cells upregulate hundreds of proliferation- related genes, along with many novel putative cell cycle components. Strikingly, genes involved in beta-cell functions, namely glucose sensing and insulin secretion were repressed. Further studies using single molecule RNA in situ hybridization revealed that in fact, replicating beta-cells double the amount of RNA for most genes, but this upregulation excludes genes involved in beta-cell function.
    [Show full text]
  • A Dissertation Entitled TRIP13 AAA-Atpase Promotes Spindle
    A Dissertation Entitled TRIP13 AAA-ATPase Promotes Spindle Assembly Checkpoint Activation through Coordinating with MAD1 at Unattached Kinetochores By Christopher E. Arnst Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Biology __________________________________________ Dr. Song-Tao Liu, Committee Chair __________________________________________ Dr. William Taylor, Committee Member __________________________________________ Dr. Qian Chen, Committee Member __________________________________________ Dr. Donald Ronning, Committee Member __________________________________________ Dr. Ajith Karunarathne, Committee Member __________________________________________ Dr. Cyndee Gruden, Dean College of Graduate Studies University of Toledo August 2019 Copyright 2019, Christopher E. Arnst This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of TRIP13 AAA-ATPase Promotes Spindle Assembly Checkpoint Activation through Coordinating with MAD1 at Unattached Kinetochores By Christopher E. Arnst Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Biology The University of Toledo August 2019 During mitosis, cells must ensure proper separation of the genome into daughter cells. Failure to evenly divide chromosomes into the daughter cells results in aneuploidy and chromosomal instability (CIN). CIN is common in aggressive
    [Show full text]
  • TRIP13 Is Expressed in Colorectal Cancer and Promotes Cancer Cell Invasion
    5240 ONCOLOGY LETTERS 12: 5240-5246, 2016 TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion KENJI KURITA1, MASAO MAEDA2, MOHAMMED A. MANSOUR2,3, TOSHIO KOKURYO1, KEISUKE UEHARA1, YUKIHIRO YOKOYAMA1, MASATO NAGINO1, MICHINARI HAMAGUCHI2 and TAKESHI SENGA2 1Department of Surgical Oncology; 2Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; 3Biochemistry Section, Department of Chemistry, Faculty of Science, Tanta University, Tanta 31527, Egypt Received June 27, 2015; Accepted August 19, 2016 DOI: 10.3892/ol.2016.5332 Abstract. Thyroid hormone receptor interactor 13 (TRIP13) proteins form hexamers to exert their biological functions. is a member of the ATPases associated with various cellular The chemical energy generated by adenosine triphosphate activities family of proteins and is highly conserved in a (ATP) hydrolysis by this family of proteins induces confor- wide range of species. Recent studies have demonstrated mational changes in the substrate proteins to modulate their that TRIP13 is critical for the inactivation of the spindle functions (3,4). assembly checkpoint and is associated with the progres- A previous study reported that certain AAA+ enzymes sion of certain cancers. In the present study, the role of are associated with tumor progression (5). For example, TRIP13 in colorectal cancer (CRC) was examined. Reverse reptin [also known as RuvB-like (RUVBL) 2] and pontin transcription-quantitative polymerase chain reaction analysis (RUVBL1) have been demonstrated to be overexpressed in revealed that TRIP13 messenger RNA was highly expressed several tumors (5). These proteins interact with c-Myc or in multiple CRC tissues. The depletion of TRIP13 in CRC β-catenin, thus modulating their transcriptional activities to cells suppressed cell proliferation, migration and invasion.
    [Show full text]
  • TRIP13 Is Expressed in Colorectal Cancer and Promotes Cancer Cell Invasion
    5240 ONCOLOGY LETTERS 12: 5240-5246, 2016 TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion KENJI KURITA1, MASAO MAEDA2, MOHAMMED A. MANSOUR2,3, TOSHIO KOKURYO1, KEISUKE UEHARA1, YUKIHIRO YOKOYAMA1, MASATO NAGINO1, MICHINARI HAMAGUCHI2 and TAKESHI SENGA2 1Department of Surgical Oncology; 2Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; 3Biochemistry Section, Department of Chemistry, Faculty of Science, Tanta University, Tanta 31527, Egypt Received June 27, 2015; Accepted August 19, 2016 DOI: 10.3892/ol.2016.5332 Abstract. Thyroid hormone receptor interactor 13 (TRIP13) proteins form hexamers to exert their biological functions. is a member of the ATPases associated with various cellular The chemical energy generated by adenosine triphosphate activities family of proteins and is highly conserved in a (ATP) hydrolysis by this family of proteins induces confor- wide range of species. Recent studies have demonstrated mational changes in the substrate proteins to modulate their that TRIP13 is critical for the inactivation of the spindle functions (3,4). assembly checkpoint and is associated with the progres- A previous study reported that certain AAA+ enzymes sion of certain cancers. In the present study, the role of are associated with tumor progression (5). For example, TRIP13 in colorectal cancer (CRC) was examined. Reverse reptin [also known as RuvB-like (RUVBL) 2] and pontin transcription-quantitative polymerase chain reaction analysis (RUVBL1) have been demonstrated to be overexpressed in revealed that TRIP13 messenger RNA was highly expressed several tumors (5). These proteins interact with c-Myc or in multiple CRC tissues. The depletion of TRIP13 in CRC β-catenin, thus modulating their transcriptional activities to cells suppressed cell proliferation, migration and invasion.
    [Show full text]
  • TRIP13 Modulates Protein Deubiquitination and Accelerates Tumor Development and Progression of B Cell Malignancies
    The Journal of Clinical Investigation RESEARCH ARTICLE TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies Can Li,1,2 Jiliang Xia,3 Reinaldo Franqui-Machin,3 Fangping Chen,2 Yanjuan He,2 Timothy Cody Ashby,1 Feixiang Teng,1 Hongwei Xu,1 Dingxiao Liu,3 Dongzheng Gai,1,2 Sarah K. Johnson,1 Frits van Rhee,1 Siegfried Janz,4 John D. Shaughnessy Jr.,1 Guido Tricot,1 Ivana Frech,3 and Fenghuang Zhan1 1Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. 2Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China. 3Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA. 4Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Multiple myeloma (MM), a terminally differentiated B cell malignancy, remains difficult to cure. Understanding the molecular mechanisms underlying the progression of MM may identify therapeutic targets and lead to a fundamental shift in treatment of the disease. Deubiquitination, like ubiquitination, is a highly regulated process, implicated in almost every cellular process. Multiple deubiquitinating enzymes (DUBs) have been identified, but their regulation is poorly defined. Here, we determined that TRIP13 increases cellular deubiquitination. Overexpression of TRIP13 in mice and cultured cells resulted in excess cellular deubiquitination by enhancing the association of the DUB USP7 with its substrates. We show that TRIP13 is an oncogenic protein because it accelerates B cell tumor development in transgenic mice. TRIP13-induced resistance to proteasome inhibition can be overcome by a USP7 inhibitor in vitro and in vivo.
    [Show full text]
  • A Genomic View of Estrogen Actions in Human Breast Cancer Cells by Expression Profiling of the Hormone-Responsive Transcriptome
    719 A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome Luigi Cicatiello1, Claudio Scafoglio1, Lucia Altucci1, Massimo Cancemi1, Guido Natoli1, Angelo Facchiano2, Giovanni Iazzetti3, Raffaele Calogero4, Nicoletta Biglia6, Michele De Bortoli5,7, Christian Sfiligoi7, Piero Sismondi6,7, Francesco Bresciani1 and Alessandro Weisz1 1Dipartimento di Patologia generale, Seconda Università degli Studi di Napoli, Vico L. De Crecchio 7, 80138 Napoli, Italy 2Istituto di Scienze dell’Alimentazione del Consiglio Nazionale delle Ricerche, Avellino, Italy 3Dipartimento di Genetica, Biologia generale e molecolare, Università di Napoli ‘Federico II’, Napoli, Italy 4Dipartimento di Scienze cliniche e biologiche, Università degli Studi di Torino, Torino, Italy 5Dipartimento di Scienze oncologiche, Università degli Studi di Torino, Torino, Italy 6Dipartimento di Discipline ostetriche e ginecologiche, Università degli Studi di Torino, Torino, Italy 7Laboratorio di Ginecologia oncologica, Istituto per la Ricerca e la Cura del Cancro, Candiolo, Italy (Requests for offprints should be addressed to A Weisz; Email: [email protected]) Abstract Estrogen controls key cellular functions of responsive cells including the ability to survive, replicate, communicate and adapt to the extracellular milieu. Changes in the expression of 8400 genes were monitored here by cDNA microarray analysis during the first 32 h of human breast cancer (BC) ZR-75·1 cell stimulation with a mitogenic dose of 17-estradiol, a timing which corresponds to completion of a full mitotic cycle in hormone-stimulated cells. Hierarchical clustering of 344 genes whose expression either increases or decreases significantly in response to estrogen reveals that the gene expression program activated by the hormone in these cells shows 8 main patterns of gene activation/inhibition.
    [Show full text]